The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-{2-Fluoro-4-[(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-prop-2-ynyl-amino]-benzoylamino}-pentanedioic acid hydrate ID: ALA169981
PubChem CID: 135543822
Max Phase: Preclinical
Molecular Formula: C25H23FN4O6
Molecular Weight: 494.48
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C#CCN(Cc1ccc2nc(C)[nH]c(=O)c2c1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)c(F)c1
Standard InChI: InChI=1S/C25H23FN4O6/c1-3-10-30(13-15-4-7-20-18(11-15)24(34)28-14(2)27-20)16-5-6-17(19(26)12-16)23(33)29-21(25(35)36)8-9-22(31)32/h1,4-7,11-12,21H,8-10,13H2,2H3,(H,29,33)(H,31,32)(H,35,36)(H,27,28,34)/t21-/m0/s1
Standard InChI Key: ZALTVGFCLRNRRP-NRFANRHFSA-N
Molfile:
RDKit 2D
36 38 0 0 0 0 0 0 0 0999 V2000
11.5333 -23.2875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5333 -24.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2454 -24.5208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2454 -22.8708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2454 -22.0458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.9574 -23.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9558 -24.1107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6667 -24.5219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3798 -24.1110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3774 -23.2847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6658 -22.8772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0905 -22.8699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8063 -23.2801 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5195 -22.8653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2366 -23.2780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9493 -22.8639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9471 -22.0380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2263 -21.6280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5166 -22.0444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6597 -21.6223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6560 -20.7973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.3724 -22.0290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0848 -21.6129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8014 -22.0217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0807 -20.7879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7928 -20.3713 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.3639 -20.3785 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.5137 -21.6056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2303 -22.0145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2354 -22.8408 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9436 -21.5997 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.8090 -24.1051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5247 -24.5153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2333 -24.9250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2207 -20.8030 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.8195 -24.5260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 7 1 0
17 18 1 0
8 9 2 0
18 19 2 0
19 14 1 0
6 4 1 0
17 20 1 0
9 10 1 0
20 21 2 0
20 22 1 0
10 11 2 0
22 23 1 0
11 6 1 0
23 24 1 6
4 5 2 0
23 25 1 0
10 12 1 0
1 2 1 0
25 26 1 0
25 27 2 0
12 13 1 0
24 28 1 0
1 4 1 0
28 29 1 0
13 14 1 0
6 7 2 0
29 30 1 0
29 31 2 0
14 15 2 0
13 32 1 0
2 3 2 0
32 33 1 0
15 16 1 0
33 34 3 0
7 8 1 0
18 35 1 0
16 17 2 0
2 36 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 494.48Molecular Weight (Monoisotopic): 494.1602AlogP: 2.06#Rotatable Bonds: 10Polar Surface Area: 152.69Molecular Species: ACIDHBA: 6HBD: 4#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.14CX Basic pKa: 6.10CX LogP: 0.52CX LogD: -3.54Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.31Np Likeness Score: -1.20
References 1. Thornton TJ, Jackman AL, Marsham PR, O'Connor BM, Bishop JA, Calvert AH.. (1992) Quinazoline antifolate thymidylate synthase inhibitors: difluoro-substituted benzene ring analogues., 35 (12): [PMID:1613755 ] [10.1021/jm00090a024 ] 2. Jackman AL, Marsham PR, Thornton TJ, Bishop JA, O'Connor BM, Hughes LR, Calvert AH, Jones TR.. (1990) Quinazoline antifolate thymidylate synthase inhibitors: 2'-fluoro-N10-propargyl-5,8-dideazafolic acid and derivatives with modifications in the C2 position., 33 (11): [PMID:2231607 ] [10.1021/jm00173a025 ] 3. Marsham PR, Jackman AL, Oldfield J, Hughes LR, Thornton TJ, Bisset GM, O'Connor BM, Bishop JA, Calvert AH.. (1990) Quinazoline antifolate thymidylate synthase inhibitors: benzoyl ring modifications in the C2-methyl series., 33 (11): [PMID:2231608 ] [10.1021/jm00173a026 ] 4. Bisset GM, Pawelczak K, Jackman AL, Calvert AH, Hughes LR.. (1992) Syntheses and thymidylate synthase inhibitory activity of the poly-gamma-glutamyl conjugates of N-[5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino ]-2-thenoyl]-L-glutamic acid (ICI D1694) and other quinazoline antifolates., 35 (5): [PMID:1372358 ] [10.1021/jm00083a008 ] 5. Srivastava V, Gupta SP, Siddiqi MI, Mishra BN.. (2010) 3D-QSAR studies on quinazoline antifolate thymidylate synthase inhibitors by CoMFA and CoMSIA models., 45 (4): [PMID:20153089 ] [10.1016/j.ejmech.2009.12.065 ]